Although our institution does not routinely assay serum IGF-II or the IGF-II/IGF-I ratio, the patient presented with refractory fasting hypoglycemia that required continuous glucose infusion and was not accompanied by any clinical or biochemical evidence of hyperinsulinemia. This evidence concerns the gene IGF2 and hyperinsulinism.